SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001764013-21-000018
Filing Date
2021-02-16
Accepted
2021-02-16 08:24:12
Documents
60
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q imvt-20201231.htm   iXBRL 10-Q 1704541
2 EX-10.1 exhibit101-bradmiddlekauff.htm EX-10.1 87875
3 EX-31.1 exhibit311-q3.htm EX-31.1 9647
4 EX-31.2 exhibit312-q3.htm EX-31.2 9676
5 EX-32.1 exhibit321-q3.htm EX-32.1 5233
6 EX-32.2 exhibit322-q3.htm EX-32.2 5241
12 image_01.jpg GRAPHIC 10564
  Complete submission text file 0001764013-21-000018.txt   6496625

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imvt-20201231.xsd EX-101.SCH 36883
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imvt-20201231_cal.xml EX-101.CAL 68281
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imvt-20201231_def.xml EX-101.DEF 256287
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imvt-20201231_lab.xml EX-101.LAB 493543
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imvt-20201231_pre.xml EX-101.PRE 346516
13 EXTRACTED XBRL INSTANCE DOCUMENT imvt-20201231_htm.xml XML 1035029
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38906 | Film No.: 21632766
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences